Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study.

AUTOR(ES)

van Bijsterveld, O P

RESUMO

Bromovinyldeoxyuridine is a potent and safe antiherpes compound that in combination with a placebo treatment promoted the partial and complete healing of herpetic epithelial disease in 22 patients in average times of 4-6 days and 8.5 days respectively. However, when BVDU was combined with 1.5 X 10(6) IU of recombinant a 2C interferon, partial and complete healing times for keratitis in 19 patients were reduced to 2-6 days and 4-6 days respectively. No toxic effects of the medications were observed in any patient.

Documentos Relacionados

• Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial.
• A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis.
• Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
• Sequential antibody changes following ulcerative herpetic keratitis.
• Atenolol eye drops in glaucoma: a double-masked, controlled study.